The infectivity of tissue culture-passed mouse cytomegalovirus (MCMV) for resident mouse peritoneal macrophages in the presence of serial dilutions of antiviral antibody was studied by fluorescent antibody staining and virus yields. Although MCMV was neutralized by high concentrations of antiserum, there was a twofold enhancement of infectivity by subneutralizing antibody concentrations. On further dilution of antiserum, significant neutralization appeared again. When F(ab')_, fragments of anti-MCMV IgG were used or when macrophages were pretreated with monoclonal antibody to Fc receptor, there was no enhancement, and no neutralization at high dilutions of antiserum. This suggests that both enhancement and high dilution neutralization are mediated via the Fc portion of IgG and Fc receptors of macrophages. Tissue culture-passed virus whose infectivity for macrophages was reduced by high dilutions of antibody was converted to a more infectious state by addition of anti-mouse immunoglobulin. Similar results were obtained with salivary gland virus, which is less infectious for macrophages and is coated with nonneutralizing antibody. Tissue culture-passed virus is known to be less virulent for suckling mice and more infectious for macrophages than salivary gland-passed virus. When tissue culture-passed virus was coated with appropriately diluted antiviral antibody, not only was its infectivity for macrophages reduced, but it also became more virulent than control virus treated with normal mouse serum. These results are interpreted in terms of the optimal density of Fc on the virus-immunoglobulin complex in relation to the density of Fc receptors on macrophages.
INTRODUCTION
Antibody-mediated enhancement of virus infectivity has been reported for togaviruses (Halstead et al., 1973; Peiris & Porterfield, 1979; Schlesinger & Brandriss, 1981) . Infection of human monocytes or mouse macrophage-like cell lines was greatly enhanced in the presence of subneutralizing amounts of antibody or by non-neutralizing antiviral antibody. Antibody enhancement of infectivity is mediated via interaction between the Fc portion of IgG and Fc receptors on macrophages (Daughaday et al., 1981; Peiris et aL, 1981) . Enhancing antibodies have been suggested as an important factor in the dengue shock syndrome (Halstead, 1980) . Mouse cytomegalovirus (MCMV) has been used extensively as a model for the clinically important human CMV (Hudson, 1979) . In an earlier study of the role of macrophages in MCMV infection in mice (Mims & Gould, 1978) we showed that resident mouse peritoneal macrophages were infected less readily by salivary gland (virulent) virus than tissue culturepassed (attenuated) virus. We have also observed that non-neutralizing antibodies are attached to salivary gland virus particles (Chong et al., 1981) . We have therefore made a closer study of the effect of antiviral antibodies on the infectivity of MCMV for macrophages, and on the relation between antibodies bound to virus particles and virus virulence.
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Viruses. The strain of MCMV was donated by Dr J. Osborn, who had developed it from the Smith strain after many passages in the salivary glands of mice. Tissue culture-passed virus (TCV) was used after 10 to 22 passages in mouse embryo fibroblasts (MEF). Plaque titration of virus on MEF was described previously (Mims & Gould, 1978) : three or four wells were inoculated with each sample, and the method gives up to 20% variation in titre on repeated assays. Salivary gland virus (SGV) was obtained 3 weeks (SGV 3w) after intravenous (i.v.) infection with 104 p.f.u, of SGV.
Mice. Specific pathogen-free male CDI mice (4 to 5 weeks old) were used. All were obtained from the Animal Breeding Centre of Guy's Hospital Medical School.
Macrophage culture. Normal resident peritoneal macrophages were obtained from mice by peritoneal lavage using MEM with 100"o newborn calf serum (NCS) and 5 units/ml heparin. The cells were cultured in rings in MEM supplemented with 10g o NCS in 5°o CO_, in air as described by Mires & Gould (1978) . After 18 h, the cells were thoroughly washed with phosphate-buffered saline (PBS), then infected and re-fed. Average cell number per ring culture at this time was 105 to2 x 105
Anti-MCMV sera. Mice were given 103 to 104 p.f.u, of SGV intraperitoneally (i.p.) followed by one or two further inoculations at 2-week intervals and bled 7 days after the last injection as described previously (Chong et al., 1981 ) . The serum neutralization titre was 1/64 to 1/256, expressed as the dilution that caused a 50 % reduction in plaque count in MEF. For preparation of anti-MCMV IgG and its F(ab'), fragment, serum was collected from 30 mice infected i.v. 3 weeks previously. Its neutralization titre was 1/16.
Preparation q/F(ab'),_j?agment ofanti-MCMV lgG. Anti-MCMV IgG was precipitated three times by one-third saturated (NH~)2SO~, digested with pepsin (Sigma, 1:60000), and purified F(ab')z was obtained with a Sephadex G-200 column (Madsen & Rodkey, 1976) . Specificity of purified F(ab') 2 was confirmed by Ouchterlony double immunodiffusion test using rabbit anti-mouse IgG Fc fragment antibody (Nordic Immunological Laboratories, Maidenhead, U.K.).
Monochmal anti-Fc receptor antibody. Monoclonal anti-Fc receptor antibody in the form of culture medium of hybridoma 2-4G2 (rat anti-mouse Fc receptor II) was donated by Dr J. S. Porterfield (Peiris et al., 1981) , This antibody has been shown to recognize Fc receptor II, which is trypsin-resistant and binds IgG2b and IgGl (Unkeless, 1979) .
Anti-mouse immunoglobulin (anti-M-IgG) . We used rabbit anti-mouse IgG (H + L) (Nordic Immunological Laboratories) because the Fc portion of rabbit IgG reacts with Fc receptors on mouse macrophages (HaeffnerCavaillon et al., 1979) . Antiserum was dialysed against PBS and inactivated at 56 °C for 30 min.
hl/ection of macrophages and fluorescent antibody (FA) staining. TCV (105 to 10 ~ p.f.u, in 0.1 ml MEM supplemented with 4o/o NCS) was preincubated with 0-1 ml of serially diluted antiserum, normal mouse serum, or control PBS at 4 °C for 1 h. Macrophage cultures were infected (0.1 ml) at 37 °C for 1 h, then washed three times with warmed MEM and incubated in medium (MEM supplemented with 10g.; NCS, 100 lag/ml penicillin and 100 ~tg/ml streptomycin). At 36 h post-infection, the cells were dried, fixed with acetone for 10 min and stained with anti-MCMV serum (1/10) at 20 °C for 30 rain, followed by fluorescein isothiocyanate-conjugated goat antimouse IgG (Nordic Immunological Laboratories). Observations were made using a Leitz Orthoplan microscope equipped for epi-illumination, with a HBO 200 lamp. The mean number of antigen-positive cells per ring was calculated after counting 3000 to 5000 cells on each ring. In different experiments, between two and five replicate ring cultures were sampled.
The virus yield from macrophage cultures was assayed on MEF after freezing ring cultures at -20 °C, thawing, and centrifuging at 2000 r.p.m. (620g) for 10 min.
RESULTS

Antibody-mediated enhancement of MCMV replication in mouse peritoneal macrophages
TCV was preincubated with serial dilutions of antibody and added to normal resident peritoneal macrophages at a m.o.i, of 1 to 10 p.f.u./cell. After 36 h, the macrophages were stained and fluorescence-positive (Fa + ve) cells were counted. Virus yield from each macrophage culture was separately assayed on MEF. Fig. 1 shows that a reduction in the number of FA + ve cells was seen with high concentrations of antibody (neutralization), but at a dilution of 5 x 10 -z there was about a twofold increase in the number infected. At further dilutions (2 x 10 -3 and 5 x 10-3), neutralization appeared again. When virus plus antiserum at 2 x 10 -3 and 5 x 10 -3 was further complexed by adding anti-M-IgG at 4°C for 1 h, neutralization was converted into enhancement (Table 1) . Similar results were obtained when virus yield was assayed on MEF. The enhancement or high dilution neutralization of infectivity was not observed when normal mouse serum was used or when TCV was treated with anti-MIgG as a control. P values were calculated by Student's t-test: *,P < 0-025: **,P < 0.005; ***,P < 0-00l. 
Enhancement of inJectivity of salivary gland virus Jot macrophages by anti-M-IgG
As we have reported, SGV taken from mice infected 3 weeks previously is coated with nonneutralizing antibody. Its infectivity for macrophages (percent macrophages infected by a given p.f.u, dose) is less than one-tenth that of TCV. This may be due to antiviral antibody bound to virus particles and the result comparable with that obtained with TCV coated with diluted antibody, as described in Fig. l . SGV, therefore, was treated with anti-mouse IgG at 4 °C for 1 h and added to macrophages at an m.o.i, of 1,0. The number of infected cells increased four-to sevenfold and virus yield from infected cultures increased by about the same amount (Table 2) . These results indicate that the infectivity of SGV for macrophages is increased if virus is coated further with anti-mouse IgG.
Effect of monoclonal anti-Fc receptor antibody on antibody-mediated enhancement
Peritoneal macrophages were pretreated with monoclonal anti-Fc receptor antibody for 30 min at 4 °C, washed with PBS three times, and then infected with TCV which had been preincubated with serial dilutions of antiviral antibody. Table 3 .
MCMV preparation TCV + normal mouse serum
(5 x 10 -3 dilution) TCV + antiserum (5 X 10 -3 dilution) SGV 3w * No. dead/no, inoculated (~o mortality). t Significantly greater than mortality in mice given TCV treated with normal mouse serum (P < 0.05 by X 2 test). :~ Significantly greater than mortality in mice given TCV treated with normal mouse serum (P < 0.01 by ~-~ test). § ND, Not done.
Mortality in 5-day-old CD-1 mice after i.p. infection with antibody-coated TCV
Fc receptor antibody there was neither enhancement nor the reduction in the number of FA + ve cells at the higher (5 x 10 -3) dilution of antiviral antibody. The enhancement of infectivity of SGV by anti-mouse IgG was also blocked by pretreatment of macrophages with anti-Fc receptor antibody (data not shown).
Does the F(ab')2 j?agment of antiviral IgG mediate enhancement ?
Anti-MCMV IgG was separated and its F(ab')2 fragment was prepared. The preparation was adjusted to the original protein concentration of the separated IgG (10mg/ml). The antiserum and F(ab')2 preparations were diluted and preincubated with MCMV and infection scored by fluorescent antibody staining. Whereas the enhancement and high dilution neutralization were observed when virus was treated with antiviral IgG diluted 10 3 and 5 x 10 -3 respectively, there were no such effects when the F(ab')2 fragment was used (Fig. 3) .
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Virulence of tissue culture-passed virus coated with non-neutralizing antibody SGV coated with non-neutralizing antibody is less infectious for macrophages, yet virulent for suckling mice. TCV, on the other hand, is attenuated for suckling mice and more infectious for macrophages. As has been described above (Fig. 1 ) TCV coated with highly diluted antibody is less infectious for macrophages than untreated control virus. We therefore studied the effect of highly diluted antibody on the virulence of TCV. Table 3 shows that TCV coated with highly diluted (5 × 10 -3) antiviral antibody by incubation at 4 °C for 1 h became almost as virulent as SGV. This result indicates that there is an inverse relationship between virus infectivity for macrophages and its virulence. The result also suggests that the non-neutralizing antibody bound to virion particles is involved in virulence.
DISCUSSION
In these experiments, infectivity of MCMV for macrophages was assayed by development of viral antigen as detected by immunofluorescence, and by appearance of infectious virus in cultures. The immunofluorescence appearances were characteristic, quite distinct from those attributable to passive uptake of virus and viral antigens, and were not seen 1 h after infection. Does the infectious virus yield from cultures represent newly synthesized virus? This has not been proven, but we believe that it does because results in the accompanying paper (Inada & Mims, 1985: Table 1) show that virus yields after a given inoculum parallel the infection rate in macrophages as determined by immunofluorescence.
As MCMV antibody was serially diluted, initial neutralization of MCMV in macrophages (to an endpoint comparable to that seen in MEF) gave way to enhancement and finally reappearance of neutralization at higher dilutions of antibody. This enhancement and high dilution neutralization was not seen when the F(ab')2 fragment of antiviral antibody was used or when macrophages were pretreated with monoclonal anti-Fc receptor antibody. Thus, both enhancement and high dilution neutralization are due to interaction between the Fc portion of IgG and Fc receptors on macrophages. The extent of enhancement, however, was small compared with that described for togaviruses (Peiris & Porterfield, 1979) . A very small and variable enhancement was seen when MEF cells were used (unpublished observations), presumably reflecting the presence of occasional Fc receptor-bearing cells in these cultures (see also Inada & Mims, 1985) . Differences in neutralizing capacity of antiserum for macrophages compared with other cell types were recently reported for canine distemper virus (Appel et al., 1984) .
The neutralization of infectivity in macrophages which reappeared at high dilutions of antibody was not seen with togaviruses (Halstead et al., 1973; Peiris & Porterfield, 1979; Schiesinger & Brandriss, 1981) . This might be due to differences in the cells, virus or antibodies employed in each study. The neutralization seen at high dilutions of antibody could be converted to enhancement by further coating the virus-antibody complex with anti-mouse globulin. This suggests that the result depends on the density of the Fc portion of IgG on the virus-antibody complex, in relation to the density of the Fc receptors on the surface of the macrophage. Perhaps when the concentration of antibody on the virion is too low, the interaction between Fc and Fc receptors is reversible, does not lead to strong or multiple binding (Griffin et al., 1976; Unanue, 1972) , and does not induce virus internalization (Shaw & Griffin, 1981) . This reversible interaction, however, may interrupt the binding between virus and virus-specific receptors, and result in reduction of infectivity. If the virus-antibody complex was treated with anti-mouse globulin at 4 °C for 1 h, the density of Fc on virus particles increased, and infectivity for macrophages increased. Similar enhanced infectivity was observed when SGV (to which mouse IgG is attached and which is less infectious for macrophages than TCV) was coated with antimouse globulin. Enhanced infectivity mediated by rabbit anti-mouse globulin was again blocked by anti-Fc receptor antibody, suggesting cross-reactivity between the Fc portion of rabbit IgG and mouse Fc receptors (Haeffner-Cavaillon et al., 1979) . We have shown (Inada & Mires, 1985) that trypsin treatment of SGV 3w significantly enhances its infectivity for macrophages. The infectivity of trypsin-treated SGV for MEF could not be reduced by incubating the virus with anti-mouse IgG Fc at 37 °C for 1 h, but could be reduced by anti-mouse IgG Fab, indicating that the trypsin treatment had removed the Fc portion of antiviral antibody. Although the infectivity of SGV 3w for MEF was substantially neutralized when incubated with antiglobulin at 37 °C for 1 h, the virus was not neutralized at 4 °C for 1 h (data not shown). A similar phenomenon has been reported for yellow fever virus in the macrophagelike cell line U937 (Schlesinger & Brandriss, 1981) where neutralization occurs when antibody plus virus is incubated at 37 °C, but enhancement of infectivity when incubation is at 4 °C. Selgrade et al. (1981) reported that salivary gland virus taken 5 weeks instead of 2 or 3 weeks after infection is less virulent, but when mice were treated with cyclophosphamide before harvest of 5 to 6 week salivary glands, this difference was not seen. This result may be understood by considering the density of IgG attached to virus particles in relation to its virulence and infectivity for macrophages. We have observed that SGV 5w is more infectious for macrophages and that its infectivity is more easily reduced by anti-mouse globulin than is the infectivity of SGV 3w (unpublished observations). Thus, SGV 5w is coated with more antiviral antibody than SGV 3w and its higher infectiousness for macrophages may be attributable to antibody-mediated enhancement. Cyclophosphamide, by reducing antiviral antibody responses in infected mice, would reduce the density of antiviral antibody on the virions.
When TCV, which itself is attenuated (Jordan & Takagi, 1983; Osborn & Walker, 1971) , was coated with highly diluted antibody its virulence was significantly enhanced, and its infectivity for macrophages was reduced. There is, therefore, much evidence for an inverse relationship between MCMV infectivity for macrophages and its virulence (Inada & Mims, 1985) . It should be noted that the TCV used had received only 10 to 22 passages in MEF, and the conversion to virulence by coating with highly diluted antibody might not have been possible with a more extensively tissue culture-passaged strain in which genetic changes associated with attenuation had taken place.
How can we account for the association between virulence and decreased infection of macrophages? Multiplication of MCMV in resident peritoneal macrophages is slow and virus yield per cell is very low when compared with permissive MEF (Jordan & Takagi, 1983 ; Mims & Gould, 1978; Shanley & Pesanti, 1983) . If decreased infection of macrophages by virulent virus was associated with decreased uptake of virus by macrophages, there would be a diversion of the inoculated virus from macrophages to other cell types, probably vascular endothelial cells, and this could lead to a more pathogenic disease process.
